GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have ...

The global cell analyzer market is projected to grow at a CAGR of 8% from 2025 to 2030, driven by the rising prevalence of ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...

The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast ...

The global AI in ultrasound imaging market is set to witness a growth rate of 22% in the next 5 years. Growing adoption of AI ...

Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative ...

In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal ...

Capital IncreaseAbivax Announces Closing of $747.5 Million Public Offering 28.07.2025 / 22:15 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax Announces Closing of ...

MiscellaneousNyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine 28.07.2025 / 22:05 CET/CESTThe issuer is solely responsible for the content of this ...

This acquisition expands neurocare’s clinic network to 11 locations in the Netherlands and marks a key step into care focused on pregnancy, early parenthood, and family wellbeing. NIJMEGEN, ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma  Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...